Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers

Health Volunteers Clinical Trial

Official title:
A Phase 1 Open-Label, Two-Period, Two-Treatment, Crossover Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers

Status Completed

Clinical Trial Summary

This is an open-label, single-dose, two period crossover study to evaluate the effect of food on the bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Health Volunteers

Clinical Trial Details

NCT number	NCT05467696
Study type	Interventional
Source	Concert Pharmaceuticals
Contact
Status	Completed
Phase	Phase 1
Start date	June 14, 2022
Completion date	July 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01765855` - An Open-Label, Single-Dose, Mass-Balance Study to Assess the Disposition of 14C-Labeled PRT054021 in Healthy Male Subjects	Phase 1
Completed	`NCT02990325` - A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults	Phase 1/Phase 2
Completed	`NCT05467709` - Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects	Phase 1
Completed	`NCT05478772` - Study to Evaluate Multiple Doses of Fluconazole, a CYP3A4 and CYP2C9 Inhibitor, on the Pharmacokinetics of CTP-543 in Healthy Subjects	Phase 1